Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23669434)


Community-acquired CTX-M-15-type ESBL-producing Escherichia coli meningitis: a case report and literature review.

Elaldi N, Gozel MG, Kolayli F, Engin A, Celik C, Bakici MZ, Vahaboglu H.

J Infect Dev Ctries. 2013 May 13;7(5):424-31. doi: 10.3855/jidc.2820. Review.


Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.

J Antimicrob Chemother. 2006 Apr;57(4):780-3. Epub 2006 Feb 21.


First initial community-acquired meningitis due to extended-spectrum beta-lactamase producing Escherichia coli complicated with multiple aortic mycotic aneurysms.

Weyrich P, Ettahar N, Legout L, Meybeck A, Leroy O, Senneville E.

Ann Clin Microbiol Antimicrob. 2012 Feb 9;11:4. doi: 10.1186/1476-0711-11-4.


The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.

Karfunkel D, Carmeli Y, Chmelnitsky I, Kotlovsky T, Navon-Venezia S.

Eur J Clin Microbiol Infect Dis. 2013 Apr;32(4):513-21. doi: 10.1007/s10096-012-1765-9. Epub 2012 Nov 2.


Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.

Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F, Butaye P.

Microb Drug Resist. 2010 Jun;16(2):129-34. doi: 10.1089/mdr.2009.0132.


CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.

Celik AD, Yulugkural Z, Kuloglu F, Eroglu C, Torol S, Vahaboğlu H, Akata F.

J Microbiol Immunol Infect. 2010 Apr;43(2):163-7. doi: 10.1016/S1684-1182(10)60026-6.


Characterization of extended-spectrum β-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm.

Ma J, Liu JH, Lv L, Zong Z, Sun Y, Zheng H, Chen Z, Zeng ZL.

Appl Environ Microbiol. 2012 May;78(10):3668-73. doi: 10.1128/AEM.07507-11. Epub 2012 Mar 9.


Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.

Lampri N, Galani I, Poulakou G, Katsarolis I, Petrikkos G, Giamarellou H, Souli M.

J Antimicrob Chemother. 2012 Oct;67(10):2424-8. doi: 10.1093/jac/dks215. Epub 2012 Jun 4.


CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.

Dubois V, De Barbeyrac B, Rogues AM, Arpin C, Coulange L, Andre C, M'zali F, Megraud F, Quentin C.

J Antimicrob Chemother. 2010 Jul;65(7):1368-71. doi: 10.1093/jac/dkq153. Epub 2010 May 13.


Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.

Kang CI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, Lee NY, Song JH.

J Clin Microbiol. 2012 Feb;50(2):312-7. doi: 10.1128/JCM.06002-11. Epub 2011 Dec 7.


In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli.

Tärnberg M, Ostholm-Balkhed A, Monstein HJ, Hällgren A, Hanberger H, Nilsson LE.

Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):981-7. doi: 10.1007/s10096-011-1183-4. Epub 2011 Feb 6.


Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.

Tamayo J, Orden B, Cacho J, Cuadros J, Gomez-Garces JL, Alos JI.

Rev Esp Quimioter. 2007 Sep;20(3):334-8.


CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.

Martinez P, Garzón D, Mattar S.

Braz J Infect Dis. 2012 Sep-Oct;16(5):420-5. doi: 10.1016/j.bjid.2012.05.001. Epub 2012 Sep 8.


Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon.

Lonchel CM, Meex C, Gangoué-Piéboji J, Boreux R, Assoumou MC, Melin P, De Mol P.

BMC Infect Dis. 2012 Mar 9;12:53. doi: 10.1186/1471-2334-12-53.


Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP.

J Antimicrob Chemother. 2008 Aug;62(2):284-8. doi: 10.1093/jac/dkn181. Epub 2008 May 2.


[Case of an elderly patient with community acquired bacterial meningitis due to extended spectrum β lactamase producing Escherichia coli].

Gon Y, Otsubo R, Murase S, Park K, Nakazawa K, Hara H.

Rinsho Shinkeigaku. 2012;52(1):12-8. Review. Japanese.


Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.

Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM.

Am J Infect Control. 2007 Nov;35(9):606-12.


Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.

Tian SF, Chen BY, Chu YZ, Wang S.

Can J Microbiol. 2008 Sep;54(9):781-5. doi: 10.1139/w08-059.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk